Skip to Content

T 115 (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint T 115 is White, Capsule-shape and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Exelan Pharmaceuticals Inc..

Lamivudine/zidovudine is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for T 115

Lamivudine and Zidovudine

Imprint:
T 115
Strength:
150 mg / 300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Exelan Pharmaceuticals Inc.
Manufacturer:
Ascent Pharmaceuticals, Inc.
National Drug Code (NDC):
76282-0115

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide